Counteracting Learned Non-use Through Augmented Visuomotor Feedback in Virtual Reality (RGS)

Desaprendiendo la parálisis Aprendida Con RGS en Pacientes Afectos de Ictus

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02657070

Enrollment

Registered

2016-01-15

Start date

2014-03-31

Completion date

2015-08-31

Last updated

2016-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiparesis

Keywords

Stroke, learned non-use, Virtual Reality, Hemiparesis

Brief summary

The purpose of this study is to determine if Reinforcement-Induced Movement Therapy (RIMT), a novel rehabilitation method that augments visuomotor feedback of movements of the patient in virtual reality, is effective in treating hemiparesis resp. learned non-use.

Interventions

BEHAVIORALReinforcement-Induced Movement Therapy (RIMT)

6 weeks, 1 session a day, 30min per sessions, of physical therapy using a VR rehabilitation gaming system (RGS) with augmented visuomotor feedback

BEHAVIORALVR-based motor rehabilitation in RGS without augmented feedback

6 weeks, 1 session a day, 30min per sessions, of physical therapy using a VR rehabilitation gaming system (RGS)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

25 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Mild-to-moderate upper-limbs hemiparesis (Proximal Medical Research Council Scale \> 2) due to ischemic or hemorrhagic stroke * Spasticity in the affected limb (Modified Ashworth Scale \<3) * First-ever ischemic or hemorrhagic stroke (\>4 weeks post-stroke) * Sufficient cognitive capacity for following the instruction of the intervention (Mini-Mental State Evaluation \>24)

Exclusion criteria

* Cognitive impairment that impede the correct execution or understanding of the intervention * Severe impairments in vision or visual perception abilities (such as vision loss or spatial neglect), in spasticity, in communication abilities (such as aphasia or apraxia), severe pain as well as other neuromuscular or orthopedic changes that impede the correct execution of the intervention training * Mental dysfunctioning during the acute or subacute phase after the stroke.

Design outcomes

Primary

Measure	Time frame	Description
The upper extremity Fugl-Meyer Assessment	at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up	change from baseline in motor function

Secondary

Measure	Time frame	Description
Chedoke Arm Hand Inventory	at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up	change from baseline in functional recovery
Barthel Index	at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up	change from baseline in activities of daily living
Hamilton Scale	at baseline, at 6-weeks (after intervention), and at 12-weeks follow-up	change from baseline in measurement of depression

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026